CDMRP Call for Applications: Peer Reviewed Medical Research Program Clinical Trial
The Department of Defense Congressionally Directed Medical Research Programs (CDMRP) announce a funding opportunity, the Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award.
The Peer Reviewed Medical Research Program (PRMRP) seeks applications in laboratory, clinical, behavioral, epidemiologic, and other areas of research to advance knowledge in disease etiology, improve prevention, detection, diagnosis, treatment, and quality of life for those affected by a relevant disease or condition, and to develop and validate clinical care or public health guidelines. The PRMRP FY21 Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the FY21 Topic Areas.
Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations.
Funding from this award mechanism must support a clinical trial and cannot be used for animal studies. Two different application categories, based on the phase of planning for the clinical trial, are available under this program announcement:
- Planning Phase with Clinical Trial: this is intended to support the final phase of regulatory activities necessary to initiate the planned clinical trial.
- Clinical Trial Only: this is intended to support a clinical trial having either FDA (or other regulatory agency) approval or an exemption; the clinical trial is expected to begin no later than 9 months after the award date.
Eligibility:
- All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.
- Investigators at or above the level of Assistant Professor (or equivalent) may be named by the organization as the PI on the application (There are no limitations on the number of applications for which an investigator may be named as a PI).
Read more here.
Pre-Application deadline May 13, 2021.
